Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced the publication of groundbreaking results from its pivotal Phase 3 Launch-HTN trial in the Journal of the American Medical ...

Objectives To explore patients’ and healthcare practitioners’ (HCPs) views about non-adherence to hypertension medication and potential content of a combined very brief face-to-face discussion (VBI) ...

Antihypertensives, Angiotensin, Glucose and Alzheimer's Disease Lucy Nelson; Naji Tabet; Cassie Richardson; Paul Gard Disclosures Expert Rev Neurother. 2013;13 (5):477-482. Angiotensin ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

The medication was apparently distributed to three states: Illinois, Mississippi, and Pennsylvania. Icosapent ethyl can be “used together with a proper diet to help control high triglyceride (fat-like ...

Abstract Background Failure to control blood pressure (BP) despite multiple prescribed antihypertensive medications (AHMs) is widespread and leads to worse clinical outcomes. Recent changes to BP ...

June 12, 2025 Evidence that antihypertensive medication (AHTN) use is associated with an increased risk of kidney cancer (KC) is emerging. However, limited evidence is available on disentangling the ...

Antihypertensive medication has an impact on development of diabetes; beyond blood-pressure lowering, the risk of diabetes is further reduced by blockade of the renin–angiotensin system (RAS).

Impact of patients’ knowledge of hypertension on adherence to antihypertensive drugs in Qassim region, Saudi Arabia by Medical Science (Journal) Publication date 2022 Usage Attribution-NoDerivs 4.0 ...